All In MedTech

FDA Clearance Tracker · P040044-S068

MYNXGRIP VASCULAR CLOSURE DEVICE (5F, 6F/7F)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 6, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 6, 2016

Approved

Time to decision

274 days

Received Dec 7, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P040044-S068
Device name
MYNXGRIP VASCULAR CLOSURE DEVICE (5F, 6F/7F)
Applicant location
Miami Lakes, FL
Received
Dec 7, 2015
Decided
Sep 6, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P040044

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MGB

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at 9020 Activity Road, Suite D, San Diego, California, 92126 for the sterilization of the Mynx Grip Vascular Closure Device (5F/6F/7F) and Mynx Ace Vascular Closure Device (5F/6F/7F).

Source documents

Other decisions for Cordis US Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.